Masitinib, a novel phenylaminothiazole-type derivative, is an inhibitor of the class III receptor tyrosine kinase stem-cell growth factor receptor (c-Kit) with IC50 of 200 nM, platelet-derived growth factor receptor α and β and the non-receptor tyrosine kinase Lyn(PDGFRα/β with IC50 of 540 nM/800 nM).
MoreFR 236924是选择性 PKCε 激动剂。
MoreD-erythro-Sphingosine (synthetic)是Protein kinase C(PKC) 抑制剂。
MoreCID 2858522是选择性抑制 PKC诱导的 NF-κB 激活。
MoreCGP 53353是PKCβII选择性抑制剂。
MoreMasitinib, a novel phenylaminothiazole-type derivative, is an inhibitor of the class III receptor tyrosine kinase stem-cell growth factor receptor (c-Kit) with IC50 of 200 nM, platelet-derived growth factor receptor α and β and the non-receptor tyrosine kinase Lyn(PDGFRα/β with IC50 of 540 nM/800 nM).
MoreFR 236924是选择性 PKCε 激动剂。
MoreD-erythro-Sphingosine (synthetic)是Protein kinase C(PKC) 抑制剂。
MoreCID 2858522是选择性抑制 PKC诱导的 NF-κB 激活。
MoreCGP 53353是PKCβII选择性抑制剂。
More